These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

191 related items for PubMed ID: 5322274

  • 21. [Effects of morphazinamide in the treatment of bronchial diseases in the course of tuberculosis].
    Bonarrigo N, Bonsignore G.
    Minerva Med; 1965 Sep 01; 56(70):2811-8. PubMed ID: 5852639
    [No Abstract] [Full Text] [Related]

  • 22. [Morphazinamede alone or associated in treatment of recent and chronic pulmonary tuberculosis. Observations on 48 cases].
    Baroni V, Sidari A.
    Minerva Med; 1965 Sep 05; 56(71):2864-72. PubMed ID: 5322581
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. [Clinical experiences with morphazinamide administered in slow venous perfusion in the treatment of pulmonary tuberculosis].
    Censi G, Orlandini GC.
    Minerva Med; 1965 Sep 05; 56(71):2881-92. PubMed ID: 5322269
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. [Advances in the treatment of pulmonary tuberculosis in children].
    Alcaide Megias J, Altet Gómez MN.
    An Esp Pediatr; 1983 Sep 05; 19 Suppl 19():12-7. PubMed ID: 6419658
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. [Combined use of various secondary antitubercular agents].
    Kekkaku; 1968 Mar 05; 43(3):45-7. PubMed ID: 4877917
    [No Abstract] [Full Text] [Related]

  • 31. [Clinical use of capromycin in pulmonary tuberculosis].
    Zierski M, Bek E.
    Gruzlica; 1969 Jul 05; 37(7):649-57. PubMed ID: 4900503
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. [On the intrapleural and intrabronchial administration of morphazinamide administered alone and in association with dexamethasone 21-orthophosphate].
    Oncina E.
    Minerva Med; 1965 Sep 01; 56(70):2818-20. PubMed ID: 5852640
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. [Causes of the emergence of drug resistance and results of the treatment of tuberculous patients at the Torzym Sanatorium].
    Ryszewski W.
    Gruzlica; 1965 Apr 01; 33(4):277-85. PubMed ID: 5319980
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. [Comparative study on rifomycin in resumption of treatment of pulmonary tuberculosis cases with polyresistant bacilli].
    Prignot J, Gyselen A, Cosemans J, De Brabandere R, Verbist L, Simon-Pouthier F.
    Acta Tuberc Pneumol Belg; 1969 Apr 01; 60(3):487-95. PubMed ID: 4906102
    [No Abstract] [Full Text] [Related]

  • 39. [Morphazinamide in the treatment of urinary tuberculosis].
    Torcello V, Cennamo L, Bianco A.
    Minerva Med; 1965 Sep 01; 56(70):2820-7. PubMed ID: 5322266
    [No Abstract] [Full Text] [Related]

  • 40. [Treatment of chronic destructive pulmonary tuberculosis by intravenous injections of morphazinamide].
    Utkin VV, Zankisova IG, Polishchuk AK, Krylova NP, Gridneva SM.
    Vrach Delo; 1972 Feb 01; 2():57-8. PubMed ID: 5084744
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.